Category: Insights

As blockbuster drugs fizzle, biotech looks warily to the next big thing

Damian Garde, Posted with permission from STAT Has the age of the biotech blockbuster come to a close? Over the past year, a string of would-be best-sellers, expected to generate…
The post As blockbuster drugs fizzle, biotech looks warily to the next b…


Americans overspend $73bn on branded drugs

File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food and Drug Administration recently released for naming both biologic medicines…
The post Americans overspend $73bn on bran…


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog